Study Director, in vivo pharmacology services

Bar Harbor, Maine
Oct 03, 2019
Nov 02, 2019
Position Type
Full Time

This is an exciting opportunity to join JAX as a Study Director for in vivo pharmacology services, Neurodegeneration!

The in vivo group assists industry and academic researchers in their drug development program, by conducting efficacy studies on carefully baselined and validated models for a variety of neurobiology indications including aging, frontotemporal degeneration, Parkinson and Alzheimer diseases.  

Study Directors  have ultimate accountability for ensuring studies are executed to the specifications of the client, following gold-standard scientific procedures, meeting or exceeding client expectations without deviation and on a specific budget. They are required to check results for inaccuracies, technical or model-related performance issues, and interpret datasets for the clients.

The successful applicant for this specific role will have a proven expertise in modelling neurodegeneration in mouse models, developing and using standardized, recognized behavioral protocols to phenotype these models, and performing histological examinations of the CNS.

The position is responsible for mentoring Project Manager(s), Senior Project Manager(s), and a team of technicians tasked with executing scientific studies on behalf of external or internal customers in a collaborative in vivo laboratory environment. In addition, the Study Director will ensure accuracy in quoting, scheduling and invoicing of the studies. She/He will also be responsible for depositing normative data from mouse models into the public domain via the Mouse Phenome Database, publications and conference presentations, to further the mission of the Jackson Laboratory.

  • PhD. in a life science is required.
  • Minimum of 4 years post-doctoral experience in a contract research laboratory, pharmaceutical or biotechnology industries, or equivalent experience.
  • Experience with in vivo study design and animal research (preferably rodents) with a proven expertise in genetically-modified models for CNS neurodegeneration as demonstrated by relevant publications,
  • Documented ability to develop and standardize phenotyping and histological assays relevant to neurodegeneration
  • Excellent management/supervisory skills and proven experience with mentoring direct reports.
  • Documented ability to develop and lead technical teams.
  • Strong leadership skills including a demonstrated ability to build key relationships, influence and motivate others.
  • Demonstrated success in making important decisions, often under some pressure and tight time deadlines, which carry large financial consequences.
  • Must have excellent human relation, communication and listening, negotiation and relationship skills
  • Excellent oral and written communication skills.